DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Prostate cancer	R-HSA-2990872	map05215	nimesulide	4495	drug-path
Non-homologous end-joining	R-HSA-5693571	map03450	nimesulide	4495	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	flumequine	3374	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	flumequine	3374	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	flumequine	3374	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	flumequine	3374	drug-path
Adherens junction	R-HSA-451386	map04520	flumequine	3374	drug-path
Olfactory transduction	R-HSA-9751605	map04740	flumequine	3374	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	flumequine	3374	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	flumequine	3374	drug-path
Asthma	R-HSA-444620	map05310	flumequine	3374	drug-path
Allograft rejection	R-HSA-9679028	map05330	flumequine	3374	drug-path
Vascular smooth muscle contraction	R-HSA-445355	map04270	flumequine	3374	drug-path
Adipocytokine signaling pathway	R-HSA-168638	map04920	alverine	15443	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	alverine	15443	drug-path
Huntington's disease	R-HSA-1643685	0	alverine	15443	drug-path
Long-term potentiation	R-HSA-9620244	map04720	alverine	15443	drug-path
RNA polymerase	R-HSA-73864	map03020	alverine	15443	drug-path
Olfactory transduction	R-HSA-9751605	map04740	methocarbamol	222284	drug-path
Primary immunodeficiency	R-HSA-5601905	map05340	methocarbamol	222284	drug-path